Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Department of Nephrology, Toronto General Hospital - University Health Network, Toronto, ON, Canada.
BMC Prim Care. 2024 Aug 19;25(1):308. doi: 10.1186/s12875-024-02564-5.
While osteoarthritis is a significant issue within the hemodialysis population and contributes to reduced quality of life, pain related to osteoarthritis is poorly managed by healthcare professionals (HCPs) in hemodialysis settings due to the absence of clinical guidance applicable to this population. The purpose of this study was to explore the perceptions of HCPs on the barriers and facilitators to using a clinical decision support tool for osteoarthritis pain management in the hemodialysis setting.
A qualitative descriptive study was conducted. Purposeful and snowball sampling techniques were used to recruit hemodialysis clinicians from academic and community settings across multiple Canadian provinces. One-to-one interviews were conducted with clinicians using a semi-structured, open ended interview guide informed by the Theoretical Domains Framework, a behavior change framework. A general inductive approach was applied to identify the main themes of barriers and facilitators.
A total of 11 interviews were completed with 3 nephrologists, 2 nurse practitioners and 6 pharmacists. Findings revealed 6 main barriers and facilitators related to the use of the clinical decision support tool. Alignment of the tool with practice roles emerged as a key barrier and facilitator. Other barriers included challenges related to the dialysis environment, varying levels of clinician comfort with pain medications, and limited applicability of the tool due to patient factors. An important facilitator was the intrinsic motivation among clinicians to use the tool.
Most participants across the included hemodialysis settings expressed satisfaction with the clinical decision support tool and acknowledged its overall potential for improving osteoarthritis pain management among patients on hemodialysis. Future implementation of the tool may be limited by existing roles and practices at different institutions. Increased collaboration among hemodialysis and primary care teams may promote uptake of the tool.
尽管骨关节炎在血液透析人群中是一个重大问题,并导致生活质量下降,但由于缺乏适用于该人群的临床指导,血液透析环境中的医疗保健专业人员(HCP)对骨关节炎相关疼痛的管理不善。本研究的目的是探讨 HCP 对在血液透析环境中使用临床决策支持工具管理骨关节炎疼痛的障碍和促进因素的看法。
进行了定性描述性研究。采用目的性和滚雪球抽样技术,从加拿大多个省份的学术和社区环境中招募血液透析临床医生。使用半结构化、开放式访谈指南,根据理论领域框架(一种行为改变框架)对临床医生进行一对一访谈。采用一般归纳方法确定障碍和促进因素的主要主题。
共完成了 11 次访谈,涉及 3 名肾病学家、2 名执业护士和 6 名药剂师。研究结果揭示了与使用临床决策支持工具相关的 6 个主要障碍和促进因素。工具与实践角色的一致性是一个关键的障碍和促进因素。其他障碍包括与透析环境相关的挑战、临床医生对疼痛药物的舒适度不同,以及由于患者因素导致工具适用性有限。一个重要的促进因素是临床医生使用该工具的内在动机。
在纳入的血液透析环境中,大多数参与者对临床决策支持工具表示满意,并承认其在改善血液透析患者骨关节炎疼痛管理方面的总体潜力。该工具的未来实施可能会受到不同机构现有角色和实践的限制。增加血液透析和初级保健团队之间的协作可能会促进该工具的采用。